Tfg Asset Management Gp LTD Keros Therapeutics, Inc. Transaction History
Tfg Asset Management Gp LTD
- $453 Million
- Q3 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 43,000 shares of KROS stock, worth $742,180. This represents 0.15% of its overall portfolio holdings.
Number of Shares
43,000
Previous 128,000
66.41%
Holding current value
$742,180
Previous $1.71 Million
60.19%
% of portfolio
0.15%
Previous 0.43%
Shares
4 transactions
Others Institutions Holding KROS
# of Institutions
169Shares Held
35.4MCall Options Held
574KPut Options Held
325K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$93 Million8.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.72MShares$46.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.71MShares$46.7 Million3.92% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.19MShares$37.8 Million10.27% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...